Patients taking drugs manufactured by Pfizer, Eli Lilly & Co., and AbbVie for arthritis may find new warnings attached to those medications. The FDA is seeking additional language warning of serious side effects and possible fatalities associated with the drugs.
The medications are part of a class of arthritis drugs known as JAK inhibitors. They work by blocking enzymes in the body known to cause arthritic inflammation ...
continue reading...
Testim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.
The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since ...
continue reading...
According to a Reuters article, the multinational drug company Takeda Pharmaceutical has agreed to pay $2.4 billion to resolve the majority of its 8,000 Actos lawsuits. This represents a $200 million increase over the company’s initial settlement offer last month. Plaintiffs in Actos lawsuits allege that Takeda failed to warn doctors and patients that its Type II diabetes medication could increase the risk of bladder ...
A Louisiana judge has ruled in a bellwether trial that Takeda Pharmaceuticals destroyed evidence that would have helped the plaintiffs prove the company hid information about the cancer risks of its diabetes drug, Actos. The evidence was a part of a case that resulted in a $9 billion Actos verdict in April, 2014.
The April ruling was the first federal jury decision in a multidistrict litigation ...
continue reading...
